Best GLP-1 Providers in West Virginia (2026)

See by medication

Looking for a specific GLP-1? Browse West Virginia providers by drug.

About GLP-1s in West Virginia

West Virginia allows telehealth GLP-1 prescriptions. West Virginia Medicaid covers GLP-1s only for type 2 diabetes.

• •West Virginia has the 3rd-highest adult obesity rate in the US at 39.7%
• •WV Medicaid restricts GLP-1 coverage to diabetes
• •Telehealth is essential for rural West Virginia residents

Top Cities for GLP-1 Treatment in West Virginia

Telehealth providers ship to all West Virginia addresses, but demand is highest in these metro areas:

Prefer an in-person clinic? Browse the West Virginia GLP-1 clinic directory →

GLP-1 Care Access in West Virginia: The Numbers

West Virginia has 213 NPI-registered in-person weight-management clinics across 42 cities — 1 with an obesity-medicine taxonomy, 89 endocrinology, and 125 bariatric — alongside 91 telehealth programs that ship to West Virginia addresses. The cheapest verified ongoing compounded semaglutide price available to West Virginia residents is $79/mo (tirzepatide: $104/mo). Full methodology and the 50-state table: GLP-1 care access by state.

Insurance & Medicaid in West Virginia

In Q1 2026, West Virginia Medicaid reimbursed approximately $25,021,572 across 25,520 GLP-1 prescriptions (all covered indications, gross before rebates — federal SDUD data; full state series here).

Most insurance plans in West Virginia cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), but coverage for obesity-only indications (Wegovy, Zepbound) is much more limited and often requires prior authorization. If your insurance won't cover brand-name GLP-1s, compounded semaglutide through telehealth is typically the most affordable option at around $189/mo.

For the exact criteria, drug list, and appeal process, read our West Virginia Medicaid GLP-1 coverage & prior-authorization guide. For coverage backdoors, Zepbound is FDA-approved for obstructive sleep apnea, and Wegovy for kidney and cardiovascular indications, which some plans cover even when they exclude weight-loss-only use.

Obesity in West Virginia

According to CDC data, 39.7% of West Virginia adults have obesity (BMI of 30 or higher). This places West Virginia at #3 out of 50 states. Access to GLP-1 medications like semaglutide and tirzepatide has expanded significantly through telehealth, helping West Virginia residents get clinically supervised weight loss treatment from home.

To choose a medication, compare the clinical-trial results behind each drug, see our best semaglutide and tirzepatide provider rankings, or track the next-generation GLP-1 pipeline.

Frequently Asked Questions